Vitro, S.A.B. de C.V.
VITOF
$0.15
-$0.51-77.27%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 184.30M | 179.84M | 177.50M | 174.29M | 174.28M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 184.30M | 179.84M | 177.50M | 174.29M | 174.28M |
| Cost of Revenue | 103.89M | 104.17M | 105.52M | 90.49M | 90.04M |
| Gross Profit | 80.42M | 75.68M | 71.98M | 83.80M | 84.24M |
| SG&A Expenses | 111.87M | 109.13M | 106.36M | 98.96M | 99.74M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -7.23M | -6.72M | -4.15M | -3.47M | -3.73M |
| Total Operating Expenses | 208.52M | 206.58M | 207.73M | 185.98M | 186.05M |
| Operating Income | -24.22M | -26.74M | -30.24M | -11.69M | -11.77M |
| Income Before Tax | 115.87M | 130.17M | 127.97M | 56.40M | -20.98M |
| Income Tax Expenses | 389.00K | 16.62M | 17.61M | 11.93M | 3.47M |
| Earnings from Continuing Operations | 115.49 | 113.55 | 110.35 | 44.47 | -24.45 |
| Earnings from Discontinued Operations | 46.66M | 58.68M | 19.26M | 19.26M | 19.26M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 162.15M | 172.23M | 129.62M | 63.73M | -5.18M |
| EBIT | -24.22M | -26.74M | -30.24M | -11.69M | -11.77M |
| EBITDA | -7.17M | -9.27M | -12.54M | -2.94M | -3.17M |
| EPS Basic | 0.34 | 0.37 | 0.29 | 0.15 | 0.01 |
| Normalized Basic EPS | 0.12 | 0.14 | 0.14 | 0.08 | -0.02 |
| EPS Diluted | 0.34 | 0.37 | 0.29 | 0.15 | 0.01 |
| Normalized Diluted EPS | 0.12 | 0.14 | 0.14 | 0.08 | -0.02 |
| Average Basic Shares Outstanding | 1.89B | 1.85B | 1.75B | 1.81B | 1.81B |
| Average Diluted Shares Outstanding | 1.89B | 1.85B | 1.75B | 1.81B | 1.81B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |